Related references
Note: Only part of the references are listed.Defining a new nomenclature for the structures of active and inactive kinases
Vivek Modi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylation
James A. H. Gilburt et al.
CHEMICAL SCIENCE (2019)
Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells
Joel Basken et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
Towards simple kinetic models of functional dynamics for a kinase subfamily
Mohammad M. Sultan et al.
NATURE CHEMISTRY (2018)
A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation
Emily F. Ruff et al.
ELIFE (2018)
Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states
Eric W. Lake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38α
Patrick Roser et al.
CHEMICAL COMMUNICATIONS (2018)
Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
Bernhard C. Lechtenberg et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Dynamic Equilibrium of the Aurora A Kinase Activation Loop Revealed by Single-Molecule Spectroscopy
James A. H. Gilburt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Metal coordination in kinases and pseudokinases
Matthias J. Knape et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
James F. Blake et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation
Karina Smorodinsky-Atias et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Dynamics of Protein Kinases: Insights from Nuclear Magnetic Resonance
Yao Xiao et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Slow Inhibition and Conformation Selective Properties of Extracellular Signal-Regulated Kinase 1 and 2 Inhibitors
Johannes Rudolph et al.
BIOCHEMISTRY (2015)
Targeting RAS-mutant Cancers: Is ERK the Key?
Meagan B. Ryan et al.
TRENDS IN CANCER (2015)
Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?
Zheng Zhao et al.
ACS CHEMICAL BIOLOGY (2014)
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases
Sanjay B. Hari et al.
CHEMISTRY & BIOLOGY (2014)
Extracellular-Regulated Kinase 2 Is Activated by the Enhancement of Hinge Flexibility
Kevin M. Sours et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
Apirat Chaikuad et al.
NATURE CHEMICAL BIOLOGY (2014)
Phosphorylation releases constraints to domain motion in ERK2
Yao Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
Erick J. Morris et al.
CANCER DISCOVERY (2013)
Structure of extracellular signal-regulated kinase 2 in complex with ATP and ADP
Jun Zhang et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2012)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
Importance of Domain Closure for the Autoactivation of ERK2
Daniel Barr et al.
BIOCHEMISTRY (2011)
Development of Extracellular Signal-Regulated Kinase Inhibitors
Kimberly Burkhard et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control
Alex M. Aronov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Hydrogen exchange solvent protection by an ATP analogue reveals conformational changes in ERK2 upon activation
T Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry
T Lee et al.
MOLECULAR CELL (2004)
Physiological concentrations of divalent magnesium ion activate the serine/threonine specific protein kinase ERK2
WF Waas et al.
BIOCHEMISTRY (2003)
Protein hydrogen exchange mechanism: Local fluctuations
H Maity et al.
PROTEIN SCIENCE (2003)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3
Y Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange
AN Hoofnagle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Contribution of surface salt bridges to protein stability
P Strop et al.
BIOCHEMISTRY (2000)
Share Paper
